Abstract |
The inhibitory effects of the 9-(2-phosphonylmethoxyethyl)adenine-related compounds (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine, (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine, (R)-9-(2-phosphonylmethoxypropyl)adenine, (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine, and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine on human hepatitis B virus replication in the human hepatoma cell line HepG2 2.2.15 and duck hepatitis B virus infection in primary duck hepatocytes were investigated. (R)-9-(2-phosphonylmethoxypropyl-2,6-diaminopurine had the lowest 50% inhibitory concentrations against hepatitis B virus and duck hepatitis B virus, 0.22 and 0.06 microM, respectively, i.e., two- to fivefold lower concentrations than required for (R)-9-(2-phosphonylmethoxypropyl) adenine and 9-(2-phosphonylmethoxyethyl) adenine. All compounds were not toxic in vitro at a concentration of 100 microM.
|
Authors | R A Heijtink, J Kruining, G A de Wilde, J Balzarini, E de Clercq, S W Schalm |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 38
Issue 9
Pg. 2180-2
(Sep 1994)
ISSN: 0066-4804 [Print] United States |
PMID | 7811041
(Publication Type: Journal Article)
|
Chemical References |
- 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine
- Antiviral Agents
- Nucleosides
- Organophosphonates
- Organophosphorus Compounds
- Purines
- Cytosine
- Adenine
|
Topics |
- Adenine
(analogs & derivatives, pharmacology)
- Animals
- Antiviral Agents
(pharmacology)
- Carcinoma, Hepatocellular
(virology)
- Cytosine
(analogs & derivatives)
- Ducks
- Hepatitis B Virus, Duck
(drug effects)
- Hepatitis B virus
(drug effects)
- Humans
- Liver
(cytology, virology)
- Liver Neoplasms
(virology)
- Nucleosides
(pharmacology)
- Organophosphonates
(pharmacology)
- Organophosphorus Compounds
(pharmacology)
- Purines
(pharmacology)
- Tumor Cells, Cultured
|